Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.98 Analyst target: $36.80 Upside: 3668.56%
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.